We understand that inspired innovation can emerge from strategic partnerships. As such, Soleva Pharma is actively exploring opportunities that will further enable our journey to become an industry-leading provider of impactful oncology supportive care therapies. We seek to in-license or acquire commercial, near-commercial and late-stage development product candidates that address significant unmet needs in our Targeted Areas of Interest.
As a privately-held, commercial-stage company, Soleva takes a flexible, collaborative approach to deal constructs. With a compact and agile leadership structure, we endeavor to review opportunities in a thorough, expeditious manner and make sound decisions on product acquisitions in targeted areas of oncology supportive care.
We look forward to learning more about your opportunity and discussing how we can work together to build a successful partnership. Please contact us at firstname.lastname@example.org.
> Oral Mucositis
> Chemotherapy-induced nausea and vomiting (CINV)
> Chemotherapy-induced neutropenia (CIN)
> Chemotherapy-induced anemia (CIA)
> Cancer cachexia
> Bone metastases
> Hand-Foot Syndrome
Copyright © 2018 Soleva Pharma - All Rights Reserved